Brief: Annexin Pharmaceuticals Q3 EBIT Loss Widens To SEK 9.6 Million
Nov 3 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* Q3 EBIT LOSS SEK 9.6 MILLION VERSUS LOSS SEK 8.2 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr7FYCpS
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed